Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Bone Marrow Transplant. 2015 Jan 19;50(3):438–443. doi: 10.1038/bmt.2014.286

Table 1. Patient Characteristics.

Patient Characteristics N (%)
Sample size 67
Patient median age, y (range) 52 (23-69)
Disease at transplantation
 Myelodysplastic syndrome 1 (1)
 Acute lymphoid leukemia 2 (3)
 Chronic lymphoid leukemia/SLL 15 (22)
 Non-Hodgkin lymphoma 41 (61)
 Hodgkin lymphoma 8 (12)
Remission status at time of transplant
 CR 34 (51)
 Active disease 33 (49)
Sex
 Male 43 (64)
 Female 24 (36)
Donor Type
 HLA-identical related 26 (39)
 HLA-matched unrelated 33 (49)
 HLA-mismatched unrelated 8 (12)
Conditioning regimen
 Non myeloablative 52 (78)
 Reduced intensity 15 (22)
Source of stem cells
 Bone marrow 1 (1)
 Mobilized blood 66 (99)
IFI Risk at Transplant
 High Risk 7 (10)
 Low Risk 60 (90)